CN112107510A - Saffron crocus moisturizing and skin beautifying mask - Google Patents
Saffron crocus moisturizing and skin beautifying mask Download PDFInfo
- Publication number
- CN112107510A CN112107510A CN202011087536.3A CN202011087536A CN112107510A CN 112107510 A CN112107510 A CN 112107510A CN 202011087536 A CN202011087536 A CN 202011087536A CN 112107510 A CN112107510 A CN 112107510A
- Authority
- CN
- China
- Prior art keywords
- percent
- extract
- glycerin
- crocus
- hydrolyzed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000124209 Crocus sativus Species 0.000 title claims abstract description 15
- 235000015655 Crocus sativus Nutrition 0.000 title claims abstract description 15
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 32
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 24
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000011187 glycerol Nutrition 0.000 claims abstract description 16
- 108010020346 Polyglutamic Acid Proteins 0.000 claims abstract description 11
- 230000001815 facial effect Effects 0.000 claims abstract description 10
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 9
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- 229920001577 copolymer Polymers 0.000 claims abstract description 9
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims abstract description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 9
- 239000011734 sodium Substances 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 8
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 8
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 8
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 claims abstract description 8
- 229940033280 alpha-arbutin Drugs 0.000 claims abstract description 8
- 229960003237 betaine Drugs 0.000 claims abstract description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920000193 polymethacrylate Polymers 0.000 claims abstract description 8
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims abstract description 8
- 229940092665 tea leaf extract Drugs 0.000 claims abstract description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 7
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 6
- 241001530056 Athelia rolfsii Species 0.000 claims abstract description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 5
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract description 5
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 5
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 5
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 5
- 239000004359 castor oil Substances 0.000 claims abstract description 5
- 235000019438 castor oil Nutrition 0.000 claims abstract description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 5
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 4
- 235000004237 Crocus Nutrition 0.000 claims abstract description 4
- 241000596148 Crocus Species 0.000 claims abstract description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract 2
- 244000144725 Amygdalus communis Species 0.000 claims abstract 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 6
- 241000382455 Angelica sinensis Species 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 4
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims description 4
- 241000167550 Centella Species 0.000 claims description 3
- 244000018633 Prunus armeniaca Species 0.000 claims description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 abstract description 7
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 230000001133 acceleration Effects 0.000 abstract description 2
- 239000006071 cream Substances 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 235000020224 almond Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- 230000000694 effects Effects 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 229940089837 amygdalin Drugs 0.000 description 3
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a saffron crocus moisturizing and beautifying facial mask which is prepared from the following components in parts by weight: glycerin, propylene glycol, sodium hyaluronate, sodium polyglutamate, beta-glucan, betaine 0, glycerin polymethacrylate, PVM/MA copolymer, angelica extract, crocus extract, alpha-arbutin, hydrolyzed almond protein, hydrolyzed sclerotium rolfsii gum, butylene glycol, centella asiatica extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, glycyrrhiza glabra root extract, chamomile flower extract, rosemary leaf extract, tea leaf extract, 1, 2-hexanediol, p-hydroxyacetophenone, PEG-40 hydrogenated castor oil and essence. The raw materials are comprehensively compatible according to the proportion, and are matched with each other, so that the skin-care whitening cream has the advantages of strong moisture retention, good oxidation resistance, skin metabolism acceleration, aging delay, good antibacterial property and whitening effect; the invention has the characteristic of strong functionality.
Description
Technical Field
The invention relates to the technical field of masks, in particular to a saffron crocus moisturizing and skin-beautifying mask.
Background
Skin care has become a study in modern times, people pay more and more attention to the problem of skin care, and the facial mask plays a great role in the process of skin care. The principle of the facial mask is that the facial mask is covered on the face for a short time, so that the external air and pollution are temporarily isolated, the skin temperature is increased, pores of the skin are expanded, water in the facial mask permeates into the horny layer of the epidermis, the skin becomes soft, and the skin is naturally bright and elastic. The skin moisture loss can be caused by factors such as temperature change and pressure caused by air conditioning, environmental pollution and season change, skin aging, metabolism slowing and the like, so that the skin is rough and dull, dry lines are formed, and a plurality of skin problems are caused.
Therefore, how to provide a mask system with strong functionality is a problem that needs to be solved by those skilled in the art.
Disclosure of Invention
In view of the above, the invention provides a saffron crocus moisturizing and beautifying facial mask with strong functionality.
In order to achieve the purpose, the invention provides the following technical scheme, which comprises the following components in parts by weight: 1 to 5 percent of glycerin, 1 to 5 percent of propylene glycol, 0.1 to 0.8 percent of sodium hyaluronate, 0.3 to 1 percent of sodium polyglutamate, 0.5 to 2 percent of beta-glucan, 0.3 to 1.5 percent of betaine, 2 to 9 percent of glycerin polymethacrylate, 0.6 to 1.3 percent of PVM/MA copolymer, 0.9 to 2 percent of angelica extract, 0.5 to 1.5 percent of crocus extract, 0.5 to 1.3 percent of alpha-arbutin, 0.3 to 1.6 percent of hydrolyzed apricot kernel protein, 0.6 to 1.6 percent of hydrolyzed sclerotium rolfsii gum, 0.6 to 1.6 percent of butanediol, 0.3 to 1.5 percent of centella extract, 0.3 to 1.5 percent of polygonum cuspidatum root extract, 0.3 to 1.5 percent of radix scutellariae extract, 0.6 to 1.6 percent of glycyrrhiza glabra root extract, 1 to 5 percent of mother chrysanthemum extract, 1 to 5 percent of rosemary leaf extract, 1 to 5 percent of tea leaf extract, 1 to 4 percent of 1, 2-hexanediol, 1 to 4 percent of p-hydroxyacetophenone, 0.1 to 0.5 percent of PEG-40 hydrogenated castor oil, 1 to 4 percent of essence, and the balance of water to 100 percent.
Preferably, in the saffron crocus moisturizing and beautifying facial mask, the raw materials have the following effects:
sodium polyglutamate: the polyglutamic acid has the function of promoting mineral absorption, has extremely strong moisturizing capability due to the special molecular structure of the polyglutamic acid, can effectively improve the moisturizing capability of the skin and promote the health of the skin;
beta-glucan: the skin care product has film forming property, can help skin to keep moisture, and has the effects of moisturizing and resisting oxidation;
PVM/MA copolymer: the product is often used as an antistatic agent and an adhesive;
and (3) Chinese angelica extract: has effects of accelerating blood circulation in skin, accelerating metabolism and delaying aging;
the crocus sativus extract: has effects of promoting blood circulation, resisting inflammation, resisting oxidation, whitening skin, preventing sunburn, and resisting aging by improving skin blood circulation, promoting skin metabolism, scavenging free radicals, inhibiting melanin deposition, accelerating speckle and decolorizing, and absorbing ultraviolet, and can be used for treating contact dermatitis, seborrheic dermatitis, pruritus, and neurodermatitis;
centella asiatica extract: has antioxidant, antiinflammatory, antibacterial and anticancer effects;
giant knotweed rhizome root extract: has effects of whitening skin, removing speckle, and resisting oxidation;
radix scutellariae extract: has antibacterial and antioxidant effects;
glycyrrhiza glabra root extract: has antibacterial, antiinflammatory, antioxidant, antiaging, ultraviolet ray preventing, sunscreen, skin whitening, skin brightening, and speckle removing effects;
mother chrysanthemum extract: has the functions of well relieving skin, resisting skin sensitivity, resisting inflammation, resisting bacteria and resisting oxidation;
rosemary extract: has anti-inflammatory, antioxidant, and antibacterial effects;
tea extract: the active substances such as tea polyphenol and the like in the skin have the effects of detoxifying and resisting radiation, and the skin-care composition is a novel natural antioxidant, has strong antioxidation at normal temperature and low concentration, has an inhibiting effect on collagenase and elastase, can prevent the content reduction or denaturation of elastin, maintains the skin elasticity, and achieves the anti-wrinkle effect.
According to the technical scheme, compared with the prior art, the saffron crocus moisturizing and skin-beautifying facial mask is disclosed and provided; the raw materials are comprehensively compatible according to the proportion, and are matched with each other, so that the skin-care whitening cream has the advantages of strong moisture retention, good oxidation resistance, skin metabolism acceleration, aging delay, good antibacterial property and whitening effect; the invention has the characteristic of strong functionality.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
the composition comprises the following components in parts by weight: 1% of glycerin, 1% of propylene glycol, 0.1% of sodium hyaluronate, 0.3% of sodium polyglutamate, 0.5% of beta-glucan, 0.3% of betaine, 2% of glycerin polymethacrylate, 0.6% of PVM/MA copolymer, 0.9% of angelica sinensis extract, 0.5% of crocus sativus extract, 0.5% of alpha-arbutin, 0.3% of hydrolyzed amygdalin, 0.6% of hydrolyzed sclerotium, 0.6% of butanediol, 0.3% of centella asiatica extract, 0.3% of polygonum cuspidatum root extract, 0.3% of scutellaria baicalensis root extract, 0.6% of glycyrrhiza glabra root extract, 1% of chamomile flos extract, 1% of rosemary leaf extract, 1% of tea leaf extract, 1, 2-hexanediol, 1% of p-hydroxyacetophenone, 0.1% of PEG-40 hydrogenated castor.
Example two:
the composition comprises the following components in parts by weight: 5% of glycerin, 5% of propylene glycol, 0.8% of sodium hyaluronate, 1% of sodium polyglutamate, 2% of beta-glucan, 1.5% of betaine, 9% of glycerin polymethacrylate, 1.3% of PVM/MA copolymer, 2% of angelica sinensis extract, 1.5% of crocus sativus extract, 1.3% of alpha-arbutin, 1.6% of hydrolyzed amygdalin, 1.6% of hydrolyzed sclerotium rolfsii gum, 1.6% of butanediol, 1.5% of centella asiatica extract, 1.5% of polygonum cuspidatum root extract, 1.5% of scutellaria baicalensis root extract, 1.6% of glycyrrhiza glabra root extract, 5% of chamomile flos extract, rosemary leaf extract, 5% of tea leaf extract, 4% of 1, 2-hexanediol, 4% of p-hydroxyacetophenone, 0.5% of PEG-.
Example three:
the composition comprises the following components in parts by weight: 1% of glycerin, 1% of propylene glycol, 0.5% of sodium hyaluronate, 0.8% of sodium polyglutamate, 0.5% of beta-glucan, 0.3% of betaine, 2% of glycerin polymethacrylate, 0.6% of PVM/MA copolymer, 0.9% of angelica sinensis extract, 0.5% of crocus sativus extract, 0.5% of alpha-arbutin, 0.9% of hydrolyzed amygdalin, 0.6% of hydrolyzed sclerotium, 0.6% of butanediol, 0.9% of centella asiatica extract, 0.9% of polygonum cuspidatum root extract, 0.3% of scutellaria baicalensis root extract, 0.6% of glycyrrhiza glabra root extract, 1% of chamomile flos extract, 1% of rosemary leaf extract, 1% of tea leaf extract, 1, 2-hexanediol, 1% of p-hydroxyacetophenone, 0.1% of PEG-40 hydrogenated castor.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other. The device disclosed by the embodiment corresponds to the method disclosed by the embodiment, so that the description is simple, and the relevant points can be referred to the method part for description.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (3)
1. The saffron crocus moisturizing and beautifying facial mask is characterized by comprising the following components in parts by weight: 1 to 5 percent of glycerin, 1 to 5 percent of propylene glycol, 0.1 to 0.8 percent of sodium hyaluronate, 0.3 to 1 percent of sodium polyglutamate, 0.5 to 2 percent of beta-glucan, 0.3 to 1.5 percent of betaine, 2 to 9 percent of glycerin polymethacrylate, 0.6 to 1.3 percent of PVM/MA copolymer, 0.9 to 2 percent of angelica extract, 0.5 to 1.5 percent of crocus extract, 0.5 to 1.3 percent of alpha-arbutin, 0.3 to 1.6 percent of hydrolyzed apricot kernel protein, 0.6 to 1.6 percent of hydrolyzed sclerotium rolfsii gum, 0.6 to 1.6 percent of butanediol, 0.3 to 1.5 percent of centella extract, 0.3 to 1.5 percent of polygonum cuspidatum root extract, 0.3 to 1.5 percent of radix scutellariae extract, 0.6 to 1.6 percent of glycyrrhiza glabra root extract, 1 to 5 percent of mother chrysanthemum extract, 1 to 5 percent of rosemary leaf extract, 1 to 5 percent of tea leaf extract, 1 to 4 percent of 1, 2-hexanediol, 1 to 4 percent of p-hydroxyacetophenone, 0.1 to 0.5 percent of PEG-40 hydrogenated castor oil, 1 to 4 percent of essence, and the balance of water to 100 percent.
2. The saffron crocus moisturizing and beautifying mask as claimed in claim 1, which is prepared from the following components in parts by weight: 1 to 3 percent of glycerin, 1 to 3 percent of propylene glycol, 0.1 to 0.5 percent of sodium hyaluronate, 0.3 to 0.8 percent of sodium polyglutamate, 0.5 to 1 percent of beta-glucan, 0.3 to 0.9 percent of betaine, 2 to 5 percent of glycerin polymethacrylate, 0.6 to 1 percent of PVM/MA copolymer, 0.9 to 1.7 percent of angelica extract, 0.5 to 0.9 percent of crocus extract, 0.5 to 1 percent of alpha-arbutin, 0.3 to 0.9 percent of hydrolyzed apricot kernel protein, 0.6 to 1 percent of hydrolyzed sclerotium rolfsii gum, 0.6 to 1 percent of butanediol, 0.3 to 0.9 percent of centella extract, 0.3 to 0.9 percent of polygonum cuspidatum root extract, 0.3 to 0.9 percent of radix scutellariae extract, 0.6 to 1 percent of glycyrrhiza glabra root extract and 1 to 3 percent of mother chrysanthemum extract, 1 to 3 percent of rosemary leaf extract, 1 to 3 percent of tea leaf extract, 1 to 3 percent of 1, 2-hexanediol, 1 to 3 percent of p-hydroxyacetophenone, 0.1 to 0.5 percent of PEG-40 hydrogenated castor oil, 1 to 3 percent of essence, and the balance of water to 100 percent.
3. The saffron crocus moisturizing and beautifying facial mask as claimed in claim 1, wherein in the raw material components, water is a solvent, glycerin, propylene glycol and 1, 2-hexanediol are humectants, sodium polyglutamate, beta-glucan, betaine, glycerin polymethacrylate, PVM/MA copolymer, angelica sinensis extract, crocus sativus extract, alpha-arbutin, hydrolyzed sweet almond protein, butylene glycol, centella asiatica extract, polygonum cuspidatum root extract, scutellaria baicalensis root extract, glycyrrhiza glabra root extract, chamomile flower extract, rosemary leaf extract and tea leaf extract are skin conditioners, p-hydroxyacetophenone is a chelating agent, PEG-40 hydrogenated castor oil is a surfactant, and essence is an aromatic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011087536.3A CN112107510A (en) | 2020-10-13 | 2020-10-13 | Saffron crocus moisturizing and skin beautifying mask |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011087536.3A CN112107510A (en) | 2020-10-13 | 2020-10-13 | Saffron crocus moisturizing and skin beautifying mask |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112107510A true CN112107510A (en) | 2020-12-22 |
Family
ID=73798004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011087536.3A Pending CN112107510A (en) | 2020-10-13 | 2020-10-13 | Saffron crocus moisturizing and skin beautifying mask |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112107510A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112716847A (en) * | 2021-01-14 | 2021-04-30 | 广州妍叶生物科技有限公司 | Whitening and repairing mask and preparation method thereof |
| CN114939094A (en) * | 2022-06-16 | 2022-08-26 | 广州市科能化妆品科研有限公司 | Soothing composition and preparation method and application thereof |
| CN116251028A (en) * | 2023-03-23 | 2023-06-13 | 海南华研胶原科技股份有限公司 | Collagen tripeptide compound for after-sun repair and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103462859A (en) * | 2013-09-27 | 2013-12-25 | 罗成 | Three-flower stagnation-removal freckle-removal facial mask and preparation method thereof |
| CN106511220A (en) * | 2016-12-30 | 2017-03-22 | 广东国方医药科技有限公司 | Dendrobium officinale moisturizing and repair sleeping mask and preparation method thereof |
| CN110101630A (en) * | 2019-04-28 | 2019-08-09 | 广州科恩生物技术有限公司 | Seven days facial masks of one kind and its preparation, application method |
-
2020
- 2020-10-13 CN CN202011087536.3A patent/CN112107510A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103462859A (en) * | 2013-09-27 | 2013-12-25 | 罗成 | Three-flower stagnation-removal freckle-removal facial mask and preparation method thereof |
| CN106511220A (en) * | 2016-12-30 | 2017-03-22 | 广东国方医药科技有限公司 | Dendrobium officinale moisturizing and repair sleeping mask and preparation method thereof |
| CN110101630A (en) * | 2019-04-28 | 2019-08-09 | 广州科恩生物技术有限公司 | Seven days facial masks of one kind and its preparation, application method |
Non-Patent Citations (1)
| Title |
|---|
| 青海智养格生物科技有限公司, 国家药品监督管理局 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112716847A (en) * | 2021-01-14 | 2021-04-30 | 广州妍叶生物科技有限公司 | Whitening and repairing mask and preparation method thereof |
| CN114939094A (en) * | 2022-06-16 | 2022-08-26 | 广州市科能化妆品科研有限公司 | Soothing composition and preparation method and application thereof |
| CN116251028A (en) * | 2023-03-23 | 2023-06-13 | 海南华研胶原科技股份有限公司 | Collagen tripeptide compound for after-sun repair and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112107510A (en) | Saffron crocus moisturizing and skin beautifying mask | |
| CN109568215B (en) | Moisturizing and moisturizing repair essence cream containing soluble beeswax and preparation method thereof | |
| CN110693756A (en) | Deep moisturizing composition and application thereof, and deep moisturizing mask | |
| CN111419761A (en) | Universal moisturizing mask liquid | |
| CN104958242A (en) | Anti-ultraviolet mask liquid and preparation method thereof | |
| CN107137319A (en) | A kind of soft quick toxin-expelling and face nourishing frost of nm | |
| CN105380843A (en) | Natural plant hydrating lotion and preparation method thereof | |
| CN110693780A (en) | Skin nourishing composition and application thereof, and skin nourishing mask liquid | |
| CN112043667A (en) | Composition for moisturizing and maintaining skin barrier, and preparation method and application thereof | |
| CN114948834A (en) | Soothing and moisturizing essence and preparation method thereof | |
| CN110859791A (en) | Skin whitening composition, application thereof and skin whitening mask | |
| CN113318019A (en) | Acne-removing gel composition containing various plant essences | |
| CN116270367A (en) | Face-cleaning acne-removing essence and preparation method thereof | |
| CN105832611B (en) | A kind of natural plant extracts composition and its preparation method and application | |
| CN104825373A (en) | Application of moderate botanical extract composition in cosmetics and preparation method thereof | |
| CN113908092A (en) | Skin acne removing and oil control soluble beautifying microneedle patch composition and preparation method thereof | |
| KR20170137553A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| CN111374935A (en) | Polypeptide-containing composition and application thereof | |
| CN112402308A (en) | Multi-effect relieving moisturizing lotion and preparation method thereof | |
| CN112370395A (en) | Amino acid facial cleanser and preparation method thereof | |
| CN112076104A (en) | Composition with skin repairing function | |
| CN111514087A (en) | Whitening and skin-brightening composition and preparation method thereof | |
| CN111450017A (en) | Beautifying essence containing fullerene and preparation method thereof | |
| KR20170136911A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| CN105878109A (en) | Skin-whitening and freckle-removing essence containing jasmine essential oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201222 |